- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-PD-L1 MEDI4736 (Durvalumab)
Total 101256 results
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
Groupe Hospitalier Pitie-SalpetriereRecruitingHeart Diseases | Cardiovascular Diseases | Vasculitis | Myocarditis | Cardiomyopathies | PericarditisFrance
-
Peking University First HospitalNot yet recruitingCarcinoma, Hepatocellular
-
AstraZenecaActive, not recruitingMelanoma | Cervical Cancer | Small Cell Lung Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Non-Small-Cell Lung Cancer | Gastroesophageal Cancer | Clear Cell Renal Cell Cancer | Squamous Cell Cancer of Head and NeckUnited States, Spain, Canada, France
-
Duke UniversityMerck Sharp & Dohme LLC; IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
Pharmassist LtdUniversity of AthensActive, not recruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaGreece
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
BrightPath BiotherapeuticsTerminated
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingSarcoma | Cervical Cancer | NSCLC | Solid Tumor, AdultChina
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Hutchison Medipharma LimitedRecruitingExtensive-Stage Small Cell Lung CancerChina
-
Vastra Gotaland RegionAstraZenecaRecruitingNSCLC, Stage IFinland, Norway, Sweden
-
Georgetown UniversityNational Cancer Institute (NCI); Mayo Clinic; Emory University; Indiana University and other collaboratorsTerminatedMetastatic Colorectal Cancer | Pancreatic Adenocarcinoma | Colorectal Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Yale UniversityTerminatedAsymptomatic MyelomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
MedImmune LLCActive, not recruitingHepatocellular CarcinomaUnited States, Italy, Spain, Taiwan, Korea, Republic of, China, Hong Kong, Japan, Singapore
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerJapan, Poland, United States, Australia, Belgium, Brazil, Canada, China, Colombia, Costa Rica, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, New Zealand, Portugal, Puerto Rico, Russian Federation, Spain, Taiwan, Ukr... and more
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingCarcinoma, Non-Small-Cell Lung | Lung Neoplasms | Carcinoma, Bronchogenic | Lung Disease | Respiratory Tract Disease | Respiratory Tract Neoplasms Nec | Neoplasm, BronchialChina
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedMelanoma | Sarcoma | Breast Cancer | Solid Tumor | Prostate Cancer | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cutaneous T-Cell Lymphoma | Renal Cancer | Merkel Cell Carcinoma | Testicular CancerUnited States
-
Dragonboat Biopharmaceutical Company LimitedShanghai East HospitalUnknown
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
MedImmune LLCCompletedStudy to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Japan
-
MedImmune LLCTerminatedCancer | Solid Tumors | CTCLUnited States, France, Canada
-
Genentech, Inc.Completed
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Daniela Matei, MDMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedEndometrial Cancer | Endometrial AdenocarcinomaUnited States
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedMetastatic Anaplastic Thyroid CancerUnited States
-
Joachim Aerts, MD PhDAIM ImmunoTech Inc.; AstraZeneca BVRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungSpain, United States, Taiwan, Belgium, Denmark, Switzerland, Argentina, Israel, Italy, Croatia, United Kingdom, Korea, Republic of, Russian Federation, Slovakia, Japan, Bulgaria, Poland, Hungary, Australia, Turkey, Peru, Chile, Mexico, Czech... and more
-
Do-Youn OhAstraZenecaActive, not recruiting
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
Peregrine PharmaceuticalsWithdrawn
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Radiopharm Theranostics, LtdRecruitingNon Small Cell Lung Cancer | PDL1 Gene MutationAustralia
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruiting
-
Phanes TherapeuticsRecruitingNon Small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingNon-small Cell Lung Cancer | Advanced Lung Carcinoma
-
Cairo UniversityNot yet recruiting